JSJohannes Salomonsson

Johannes Salomonsson

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Johannes Salomonsson has a total of 26 co-authors. Here are the top co-authors by number of shared publications:

  • Alexandra Ahlner

    Department of Physics, Chemistry and Biology, Division of Chemistry, Linköping University, Linköping, Sweden

    3 shared publications
  • Maria Sunnerhagen

    Department of Physics, Chemistry and Biology, Division of Chemistry, Linköping University, Linköping, Sweden

    3 shared publications
  • Alexandra Ahlner

    Department of Physics, Chemistry and Biology, Linköping University, SE-58183, Linköping, Sweden

    2 shared publications
  • Arjan Mofers

    Department of Medical and Health Sciences, Linköping University, SE-58183, Linköping, Sweden

    2 shared publications
  • Arvid Eskilson

    Department of Physics Chemistry and Biology, Linköping University Linköping Sweden

    2 shared publications
  • Belen Espinosa

    Division of Biochemistry, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, SE-17177, Stockholm, Sweden

    2 shared publications

Latest Publications

  • Open Access

    Dynamic networks connect the USP14 active site region with the proteasome interaction surface

    by Johannes Salomonsson, Linda Sjöstrand, Arvid Eskilson, Dean Derbyshire, Pádraig D'ARcy, Maria Sunnerhagen, Alexandra Ahlner

    Ubiquitin‐specific protease 14 (USP14) is a member of the USP family responsible for the catalytic removal of ubiquitin (Ub) from proteins directed to the proteasome, implicated in the pathogenesis of neurodegeneration and cancer. Crystallography and cryo‐EM analysis have identified loop regions crucial for the deubiquitinase activity of USP14, specifically those involved in Ub and proteasome binding. However, the structural changes in USP14 upon ligand binding to these regions are minimal, indicating significant yet uncharacterized dynamic contributions to its function. In this study, through structural and dynamical NMR experiments and functional evaluation, we demonstrate that small mutations designed to impact Ub binding and catalytic activity without disturbing the USP structure display both local and long‐range effects. The affected residues connect the catalytic site and the Ub binding region with the proteasome interaction surface through a network of loops, which show varied dynamics on the ps–ms time scale. Collectively, our findings experimentally reveal different aspects of dynamic connections within USP14, suggesting the presence of allosteric networks that link enzyme activity with regulatory function. The identification of coupled clusters of possible allostery participants in the free USP domain provides new insights into the dynamic regulation of USP14, with potential implications for understanding its role in cellular processes.


  • Open Access

    Dynamic regions allosterically connect the USP14 active site with the proteasome interaction surface

    by Johannes Salomonsson, Linda Sjöstrand, Arvid Eskilson, Dean Derbyshire, Pádraig D’arcy, Maria Sunnerhagen, Alexandra Ahlner

    U biquitin- s pecific p rotease 14 (USP14), is a member of the USP family responsible for the catalytic removal of ubiquitin (Ub) from proteins directed to the proteasome, implicated in the pathogenesis of neurodegeneration and cancer. Crystallography and cryo-EM analysis have identified loop regions crucial for the deubiquitinase activity of USP14, specifically those involved in Ub and proteasome binding. However, the structural changes in USP14 upon ligand binding to these regions are minimal, indicating significant yet uncharacterized dynamic contributions to its function. In this study, through structural and dynamical NMR experiments and functional evaluation, we demonstrate that small mutations designed to impact Ub binding and catalytic activity without disturbing the USP structure display both local and long-range effects. The affected residues connect the active site and the Ub binding region with the proteasome interaction surface through a network of loops, which show varied dynamics on the ps-ms time scale. Collectively, our findings experimentally reveal different aspects of dynamic connections within USP14, suggesting the presence of allosteric networks that link enzyme activity with regulatory function. The novel concept that USP14 allosteric networks are pre-existing, coupled, and activated by regulatory interactions with the USP fold, could be crucial to future targeted drug design.

  • Open Access

    Transient interdomain interactions in free USP14 shape its conformational ensemble

    by Johannes Salomonsson, Björn Wallner, Linda Sjöstrand, Pádraig D'ARcy, Maria Sunnerhagen, Alexandra Ahlner

    The deubiquitinase (DUB) ubiquitin‐specific protease 14 (USP14) is a dual domain protein that plays a regulatory role in proteasomal degradation and has been identified as a promising therapeutic target. USP14 comprises a conserved USP domain and a ubiquitin‐like (Ubl) domain separated by a 25‐residue linker. The enzyme activity of USP14 is autoinhibited in solution, but is enhanced when bound to the proteasome, where the Ubl and USP domains of USP14 bind to the Rpn1 and Rpt1/Rpt2 units, respectively. No structure of full‐length USP14 in the absence of proteasome has yet been presented, however, earlier work has described how transient interactions between Ubl and USP domains in USP4 and USP7 regulate DUB activity. To better understand the roles of the Ubl and USP domains in USP14, we studied the Ubl domain alone and in full‐length USP14 by nuclear magnetic resonance spectroscopy and used small angle x‐ray scattering and molecular modeling to visualize the entire USP14 protein ensemble. Jointly, our results show how transient interdomain interactions between the Ubl and USP domains of USP14 predispose its conformational ensemble for proteasome binding, which may have functional implications for proteasome regulation and may be exploited in the design of future USP14 inhibitors.


  • Open Access

    Author Correction: Cytotoxic unsaturated electrophilic compounds commonly target the ubiquitin proteasome system

    by Karthik Selvaraju, Arjan Mofers, Paola Pellegrini, Johannes Salomonsson, Alexandra Ahlner, Vivian Morad, Ellin-Kristina Hillert, Belen Espinosa, Elias S. J. Arnér, Lasse Jensen, et al.

    An amendment to this paper has been published and can be accessed via a link at the top of the paper.


  • Open Access

    Cytotoxic unsaturated electrophilic compounds commonly target the ubiquitin proteasome system

    by Karthik Selvaraju, Arjan Mofers, Paola Pellegrini, Johannes Salomonsson, Alexandra Ahlner, Vivian Morad, Ellin-Kristina Hillert, Belen Espinosa, Elias S. J. Arnér, Lasse Jensen, et al.

    A large number of natural products have been advocated as anticancer agents. Many of these compounds contain functional groups characterized by chemical reactivity. It is not clear whether distinct mechanisms of action can be attributed to such compounds. We used a chemical library screening approach to demonstrate that a substantial fraction (~20%) of cytotoxic synthetic compounds containing Michael acceptor groups inhibit proteasome substrate processing and induce a cellular response characteristic of proteasome inhibition. Biochemical and structural analyses showed binding to and inhibition of proteasome-associated cysteine deubiquitinases, in particular ubiquitin specific peptidase 14 (USP14). The results suggested that compounds bind to a crevice close to the USP14 active site with modest affinity, followed by covalent binding. A subset of compounds was identified where cell death induction was closely associated with proteasome inhibition and that showed significant antineoplastic activity in a zebrafish embryo model. These findings suggest that proteasome inhibition is a relatively common mode of action by cytotoxic compounds containing Michael acceptor groups and help to explain previous reports on the antineoplastic effects of natural products containing such functional groups.